D Molecular Therapeutics reported 52-week Phase 2b data for 4D-150 in wet AMD, showing sustained visual acuity improvements.

Regeneron Pharmaceuticals Inc. (REGN) announced encouraging outcomes from the Phase 3 QUASAR trial, which evaluated the efficacy of ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...

This is referred to as vitreous wick syndrome and is a high-risk situation for endophthalmitis; it should be returned to the surgery center immediately. Second, the higher level of inflammation ...

While it affects more than 500 plant species worldwide, it rarely causes disease in humans. They report a case of endophthalmitis and undertook a literature review to identify previous infections with ...

These drugs can cause some similar and some different side effects. For example, both drugs have a risk of endophthalmitis, retinal detachment, and wet AMD. (To learn more about these side effects ...

Detailed price information for 4D Molecular Therapeutics Inc (FDMT-Q) from The Globe and Mail including charting and trades.

Blurry vision usually goes away after a while. But it can sometimes be a symptom of a serious side effect such as endophthalmitis (infection in your eye) or retinal detachment. (Find out more ...

Oswal was admitted to the Military Hospital at Wanawadi on January 29, 1999, where he was diagnosed with endophthalmitis. Oswal underwent an operation and lost vision in his right eye, culminating in ...

Medically reviewed by Johnstone M. Kim, MD Red eyes are caused when blood vessels in the sclera (white part of the eye) swell ...